Unichem Laboratories obtained ANDA popularity of its Divalproex Sodium Extended-Release Tablets USP, 250 mg and 500 mg from the USA Food and Drug Administration (USFDA) to market a usual model Depakote ER (Divalproex Sodium) Extended-Release Tablets 250 mg and 500 mg, of AbbVie Inc.
Divalproex Sodium Extended-Release Tablets are indicated for remedy of acute manic or blended episodes associated with bipolar disease, as monotherapy and adjunctive
remedy and prophylaxis of migraine headaches. The product may be commercialized from Unichem’s Goa Plant.
Bazaarinformation team has many years of experience, covering the physical and future commodities markets with prominent commodity & equity trading advising which shines further with extensive network to get research from ground levels to generate proper reporting and movements. We are able to get evens out of odds in volatile markets and stockings. ...
